Drug Profile
Capravirine
Alternative Names: AG-1549; S-1153Latest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Shionogi
- Class Antiretrovirals; Imidazoles; Inorganic sulfur compounds; Small molecules
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 11 Mar 2005 Data presented at the 12th Conference on Retroviruses and Opportunistic Infections (CROI-2005) have been added to the adverse events and Viral Infections therapeutic trials sections
- 08 Feb 2005 A clinical study has been added to the adverse events and pharmacokinetics sections
- 31 Oct 2003 Data presented at the 41st Annual Meeting of the Infectious Diseases Society of America (IDSA-2003) have been added to the Viral Infections antimicrobial activity section